MODY - En autosomalt dominant form av diabetes - Diagnos via gentestning ger bättre behandling

Lakartidningen

Volumn 104, Issue 37, 2007, Pages 2600-2602

  Karlsson, Ella ^a   Groop, Leif ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD; GENETIC PROCEDURES; GENETIC SCREENING; GENETICS; HUMAN; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRESCHOOL CHILD; SHORT SURVEY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; GENETIC SCREENING; GENETIC TECHNIQUES; HUMANS; MUTATION; PHENOTYPE;

EID: 35648935397     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975;24:44-53.
2. Hattersley AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998;15:15-24.
3. Lehto M, Wipemo C, Ivarsson SA, Lindgren C, Lipsanen-Nyman M, Weng J, et al. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes. Diabetologia 1999;42:1131-7.
4. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004;89:526-9.
5. Pruhova S, Ek J, Lebl J, Sumnik Z, Saudek F, Andel M, et al. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha. Diabetologia 2003;46:291-5.
6. Barrio R, Bellanne-Chantelot C, Moreno JC, Morel V, Calle H, Alonso M, et al. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002;87:2532-9.
7. Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 2005;48:878-85.
8. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, et al. beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001;50 Suppl 1:S94-100.
9. Furuta H, Furuta M, Sanke T, Ekawa K, Hanabusa T, Nishi M, et al. Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type 2 diabetes in Japanese. J Clin Endocrinol Metab 2002;87:3859-63.
10. Sagen JV, Baumann ME, Salvesen HB, Molven A, Sovik O, Njolstad PR. Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus. Diabet Med 2005;22:1012-5.
11. Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes 1997;46:1749-54.
12. Lehto M, Bitzen PO, Isomaa B, Wipemo C, Wessman Y, Forsblom C, et al. Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism. Diabetes 1999;48:423-5.
13. Shih DQ, Dansky HM, Fleisher M, Assmann G, Fajans SS, Stoffel M. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 2000;49:832-7.
14. Prisco F, Iafusco D, Franzese A, Sulli N, Barbetti F. MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of "neonatal diabetes"? Diabetologia 2000;43:1331-2.
15. Sakura H, Kawamori R, Kubota M, Morishima T, Kamada T, Akanuma Y, et al. Glucokinase gene mutation and impaired glucose uptake by liver. Lancet 1993;341:1532-3.
16. Velho G, Petersen KF, Perseghin G, Hwang JH, Rothman DL, Pueyo ME, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 1996;98:1755-61.
17. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998;19:268-70.
18. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, et al. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest 1997;99:582-91.
19. Menzel S, Yamagata K, Trabb JB, Nerup J, Permutt MA, Fajans SS, et al. Localization of MODY3 to a 5-cM region of human chromosome 12. Diabetes 1995;44:1408-13.
20. Shih DQ, Stoffel M. Dissecting the transcriptional network of pancreatic islets during development and differentiation. Proc Natl Acad Sci U S A 2001;98:14189-91.
21. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, et al. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 1998;41:467-73.
22. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003;362:1275-81.
23. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997;15:106-10.
24. Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004;140:510-7.
25. Liljestrom B, Aktan-Collan K, Isomaa B, Sarelin L, Uutela A, Groop L, et al. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer. Diabetologia 2005;48:242-50.
26. Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 2003;26:3191-2.